The Big Development In offices from New York to Nairobi, a curious pattern is emerging: professionals are doing more work in ...

How close are we to the sci-fi vision of autonomous humanoid robots? I visited 11 companies in five Chinese cities to find out ...

Gabelli Funds Annual Specialty Chemicals Symposium March 19, 2026 1:30 PM EDTCompany ParticipantsWilliam Whitaker - Senior VP, CFO ...

As a reminder, today's earnings release, presentation, and statements made during this call include forward-looking statements under federal securities laws. Initial price is always important, but ...

Q4 2025 Earnings Call March 12, 2026 4:30 PM EDTCompany ParticipantsRobert Eno - CEO, Chief Business Officer & ...

Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...

When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or only MSI-positive tumors, accuracy fell substantially, revealing that the ...

HeartBeam, Inc. (NASDAQ:BEAT) Q4 2025 Earnings Call Transcript March 12, 2026 HeartBeam, Inc. misses on earnings expectations. Reported EPS is $-0.15728 EPS, expectations were $-0.1375. Operator: ...

After college, she’d struggled to make a living as a freelance journalist, gone to grad school, then pivoted to what she hoped would be a more stable career in content marketing — only to find AI had ...

Kyntra Bio(NASDAQ:KYNB) reported that its rebranding, asset sale, and debt payoff have shifted the company’s financial structure and enabled a clinical focus on oncology and rare disease. Management ...

AI is rapidly reshaping the landscape of surgical oncology. However, its true potential lies not in isolated tools, but rather ...